https://www.selleckchem.com/pr....oducts/netarsudil-ar
We also discuss limitations in these studies and future directions for the field, particularly if high-dimensional imaging data are to play a larger role in precision medicine.[This corrects the article DOI 10.1093/hropen/hoaa063.].Purpose Up to 1.8% of youth identify as transgender; many will be treated with a gonadotropin-releasing hormone agonist (GnRHa). The impact of GnRHa on insulin sensitivity and body composition in transgender youth is understudied. We aimed to evaluate differences in insulin sensitivity and body co
Like
Comment
Share
